MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2 - Li, Peilong; Zhang, Xin; Wang, Haiyan; Wang, Lili; Liu, Tong; Du, Lutao; Yang, Yongmei; Wang, Chuanxin (Molecular cancer therapeutics, 2017)
Keywords: 3' Untranslated Regions; 5-Fluorouracil; Cancer; Cancer therapies; Cell Line, Tumor; Chemoresistance; Chemotherapy; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - drug therapy; Colorectal Neoplasms - genetics; Drug Resistance, Neoplasm; E-cadherin; Enhancer of Zeste Homolog 2 Protein - genetics; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene regulation; HT29 Cells; Humans; Mesenchyme; Metastases; Metastasis; MicroRNAs - genetics; Non-coding RNA; Organoplatinum Compounds - administration & dosage; Organoplatinum Compounds - pharmacology; Oxaliplatin; Patients; Prognosis; Ribonucleic acid; RNA; RNA, Long Noncoding - genetics; Survival Analysis; Transcription